Last reviewed · How we verify

NCT04949373

High Intensity Laser Therapy in Carpal Tunnel Syndrome

Completed NA Last updated 22 November 2022
What this trial tests

NA trial testing High-intensity laser therapy (HILT) in Carpal Tunnel Syndrome in 60 participants. Completed in 15 November 2022.

Timeline
1 June 2021
Primary endpoint
27 June 2022
15 November 2022

Quick facts

Lead sponsorAfyonkarahisar Health Sciences University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment60
Start date1 June 2021
Primary completion27 June 2022
Estimated completion15 November 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Afyonkarahisar Health Sciences University

Who can join

Adults 18 to 65, any sex, with Carpal Tunnel Syndrome or Entrapment Neuropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research aims to investigate the effect of high-intensity laser therapy on pain, function, nerve conduction studies and grip strength in patients with idiopathic carpal tunnel syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of High-intensity laser therapy (HILT)

Trials testing the same drug.

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

Other Afyonkarahisar Health Sciences University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04949373.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing